ACTA DERM-VENEREOL 润色咨询

ACTA DERMATO-VENEREOLOGICA

出版年份：1920 年文章数：2191 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：10.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2024-01-31 ms3000000143439682 来自湖南省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：皮肤病
    经验分享：建议试试

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2021-05-12 daizii

    没有审稿意见？

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2023-05-26 梁丽玲 来自浙江省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：皮肤病学
    经验分享：较慢,6-12周

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    是否需要在讨论中说明文章局限性？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2021-12-28 ms6000000264964247

    讨论中局限性怎么撰写？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2018-09-27 ms9916001427840442

    审稿速度:1.0
    经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2185064, encodeId=bff7218506484, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：皮肤病<br>经验分享：建议试试<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecc9163949, createdName=ms3000000143439682, createdTime=Wed Jan 31 17:47:23 CST 2024, time=2024-01-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=964898, encodeId=482196489882, content=没有审稿意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e64e1725624, createdName=daizii, createdTime=Wed May 12 13:26:41 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139236, encodeId=60aa21392364b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：皮肤病学<br>经验分享：较慢,6-12周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Fri May 26 16:49:07 CST 2023, time=2023-05-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1085991, encodeId=8f7f1085991a1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085992, encodeId=5cc310859925d, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847443, encodeId=0b1684e443df, content=审稿速度:1.0<br>经验分享：皮肤病学比较好的期刊，这两年可能关注的人少了所以投稿的人也少了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af075413983, createdName=ms9916001427840442, createdTime=Thu Sep 27 10:16:56 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536618, encodeId=9801536618fc, content=审稿费100欧，拒稿不退！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=415, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6fbd2058910, createdName=Miss嵬, createdTime=Thu May 11 11:04:00 CST 2017, time=2017-05-11, status=1, ipAttribution=)]
    2017-05-11 Miss嵬

    审稿费100欧，拒稿不退！！！

    0

共15条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分